135 related articles for article (PubMed ID: 22916350)
1. [Dermatological side effects in cancer therapy].
Thoms KM; Kretschmer L
J Dtsch Dermatol Ges; 2012 Jul; 10(7):451-2. PubMed ID: 22916350
[No Abstract] [Full Text] [Related]
2. Skin toxicity of anti-cancer therapy.
Ulrich J; Hartmann JT; Dörr W; Ugurel S
J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
[TBL] [Abstract][Full Text] [Related]
3. [Skin changes as a result of targeted therapies in oncology patients: cutaneous side effects of targeted therapies in oncology patients].
Kähler KC; Hauschild A
Hautarzt; 2009 May; 60(5):433-40. PubMed ID: 19430753
[TBL] [Abstract][Full Text] [Related]
4. Side effects of systemic oncological therapies in dermatology.
Zimmer L; Vaubel J; Livingstone E; Schadendorf D
J Dtsch Dermatol Ges; 2012 Jul; 10(7):475-86. PubMed ID: 22571234
[TBL] [Abstract][Full Text] [Related]
5. [Cutaneous side effects of medical tumor therapy].
Degen A; Alter M; Schenck F; Kapp A; Gutzmer R
Hautarzt; 2011 Jun; 62(6):444-50. PubMed ID: 21503784
[TBL] [Abstract][Full Text] [Related]
6. [Drug reactions caused by chemotherapy agents].
Ehmann LM; Schrumpf H; Gerber PA; Homey B
Hautarzt; 2014 May; 65(5):443-9. PubMed ID: 24820802
[TBL] [Abstract][Full Text] [Related]
7. Extravasation of docetaxel.
Cifuentes L; Ring J; Brockow K
J Dtsch Dermatol Ges; 2012 Sep; 10(9):662-3. PubMed ID: 22734918
[No Abstract] [Full Text] [Related]
8. Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician.
Gutzmer R; Becker JC; Enk A; Garbe C; Hauschild A; Leverkus M; Reimer G; Treudler R; Tsianakas A; Ulrich C; Wollenberg A; Homey B
J Dtsch Dermatol Ges; 2011 Mar; 9(3):195-203. PubMed ID: 21059173
[TBL] [Abstract][Full Text] [Related]
9. [Skin changes with chemotherapy].
Branzan AL; Landthaler M; Szeimies RM
Hautarzt; 2005 Jun; 56(6):591-602; quiz 603. PubMed ID: 15909151
[TBL] [Abstract][Full Text] [Related]
10. [Allergic dermatoses caused by cytostatics and their prevention].
Selisskiĭ GD; Somov BA; Skripkin IuK; Shaparenko MV; Ado VA
Sov Med; 1977 Jul; (7):64-7. PubMed ID: 143075
[No Abstract] [Full Text] [Related]
11. [Drug-induced pruritus].
Maleki K; Weisshaar E
Hautarzt; 2014 May; 65(5):436-42. PubMed ID: 24820801
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib-induced dermatologic side-effects.
Bovenschen HJ; Alkemade JA
Int J Dermatol; 2009 Mar; 48(3):326-8. PubMed ID: 19261029
[No Abstract] [Full Text] [Related]
13. [Dermatological reactions in patients in antineoplastic therapy].
Prasad SC; Vestergaard H; Bygum A
Ugeskr Laeger; 2014 May; 176(11):. PubMed ID: 25096844
[TBL] [Abstract][Full Text] [Related]
14. Preventing and recognizing drug eruptions of the skin.
Johnson A
Lippincotts Prim Care Pract; 1999; 3(3):268-70. PubMed ID: 10711127
[No Abstract] [Full Text] [Related]
15. Dermatological adverse reactions to cancer chemotherapy.
Pavey RA; Kambil SM; Bhat RM
Indian J Dermatol Venereol Leprol; 2015; 81(4):434. PubMed ID: 26144855
[No Abstract] [Full Text] [Related]
16. Chemotherapy extravasation injuries.
Hahn JC; Shafritz AB
J Hand Surg Am; 2012 Feb; 37(2):360-2. PubMed ID: 22154720
[No Abstract] [Full Text] [Related]
17. [Sorafenib: effectiveness versus safety. Prevention of hand-foot syndrome].
Delgado-Téllez L; Campos Fernández de Sevilla MA; Tutau F
Farm Hosp; 2009; 33(5):288-9. PubMed ID: 19775581
[No Abstract] [Full Text] [Related]
18. Pityriasis rosea-like drug eruption related to rituximab treatment.
Sezer E; Erkek E; Cetin E; Sahin S
J Dermatol; 2013 Jun; 40(6):495-6. PubMed ID: 23442055
[No Abstract] [Full Text] [Related]
19. Papulopustular eruptions in a 32-year-old woman after lung cancer treatment.
Pongcharoen P; Chanprapaph K; Vachiramon V
Arch Dermatol; 2011 Jun; 147(6):735-40. PubMed ID: 21690542
[No Abstract] [Full Text] [Related]
20. Sorafenib-associated psoriasiform skin changes.
Laquer V; Saedi N; Dann F; Kelly K
Cutis; 2010 Jun; 85(6):301-2. PubMed ID: 20666190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
